{"contentid": 488052, "importid": NaN, "name": "Thromboembolic events don\u00e2\u0080\u0099t appear higher in vaccinated population, EMA says", "introduction": "As of lunchtime on Tuesday, 11 European countries had halted the rollout of COVID-19 Vaccine AstraZeneca after a number of cases of blood clots.", "content": "<p>As of lunchtime on Tuesday, 11 European countries had halted the rollout of COVID-19 Vaccine AstraZeneca after a number of cases of blood clots.</p>\n<p>Experts from the World Health Organization and the European Medicines Agency (EMA) are meeting to review the vaccine, although both agencies, along with the UK regulator, have said there is no evidence of a link to the instances of blood clots.</p>\n<p><span class=\"pullQuote\">\"Many thousands of people develop blood clots annually in the European Union for different reasons\"</span>A press briefing is due to be held by the EMA later on Tuesday to provide an update on findings from the EMA&rsquo;s investigations.</p>\n<p>The EMA&rsquo;s latest statement on the issue seeks to calm any fears across Europe that the vaccine might not be safe, stressing that the national authorities only halted the rollout as a precaution.</p>\n<p>&ldquo;Events involving blood clots, some with unusual features such as low numbers of platelets, have occurred in a very small number of people who received the vaccine,&rdquo; the statement reads. &ldquo;Many thousands of people develop blood clots annually in the European Union for different reasons. The number of thromboembolic events overall in vaccinated people seems not to be higher than that seen in the general population.</p>\n<p>&ldquo;The EMA is working closely with the company, with experts in blood disorders, and with other health authorities including the UK&rsquo;s Medicines and Healthcare products Regulatory Agency based on its experience with around 11 million administered doses of the vaccine.&rdquo;</p>\n<p>The EMA&rsquo;s Pharmacovigilance Risk Assessment Committee has called an extraordinary meeting for Thursday to make a conclusion on new information that it has gathered on the vaccine, and to provide a further update on any further actions that may need to be taken.</p>\n<p>&ldquo;While its investigation is ongoing, the EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects,&rdquo; the statement adds.</p>", "date": "2021-03-16 12:31:00", "meta_title": NaN, "meta_keywords": "blood, vaccine, clots, European, number, people, events, Tuesday, halted, rollout, COVID-, AstraZeneca, thromboembolic, don\u00e2\u0080\u0099t, higher, population, cases", "meta_description": "As of lunchtime on Tuesday, 11 European countries had halted the rollout of COVID-19 Vaccine AstraZeneca after a number of cases of blood clots.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-16 12:00:21", "updated": "2021-03-16 12:31:57", "access": NaN, "url": "https://www.thepharmaletter.com/article/thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "covid_astrazeneca_vaccine_large.png", "image2id": "covid_astrazeneca_vaccine_small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": "Blood clots", "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, European Medicines Agency, Focus On, Regulation", "geography_tag": "Europe, Sweden, UK", "company_tag": "AstraZeneca", "drug_tag": "COVID-19 Vaccine AstraZeneca", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-16 12:31:00"}